MetaCap

Intelligent Bio Solutions (INBS) vs NeuroOne Medical Technologies (NMTC)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

NeuroOne Medical Technologies is the larger company by market cap ($5.9 million vs $4.6 million), about 1.3 times the size. NeuroOne Medical Technologies converts more of its revenue into profit, with a net margin of -39.6% versus -294.9%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

INBS-12.58%NMTC-41.25%
+48%+1%-46%
Oct 7, 20261 yearNov 20, 2026
INBS-9.15%NMTC-41.78%
+32%-7%-45%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

INBS versus NMTC key metrics
MetricINBSNMTC
Share price$1.39$0.6521
Market cap$4.61M$5.94M
1-day change-7.95%-3.38%
YTD return—-85.66%
1-year return—-82.91%
5-year return—-95.19%
Forward P/E3.97—
EPS (TTM)$-6.38$-0.99
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$4.22M$9.10M
Revenue growth (YoY)+38.09%+163.47%
Net income (latest FY)$-12.43M$-3.61M
Gross margin48.63%56.51%
Operating margin-299.11%-46.46%
Net margin-294.91%-39.63%
52-week high$24.90$6.12
52-week low$1.35$0.61
Distance from 52-week high-94.42%-89.34%
Analyst consensusnonestrong_buy
Avg. price target upside+763.31%+1014.86%
Average volume129.01K337.67K
Shares outstanding3.32M9.11M
Employees5918
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • NeuroOne Medical Technologies is more profitable, keeping -39.6 cents of every revenue dollar as net income versus -294.9 cents for Intelligent Bio Solutions.
  • NeuroOne Medical Technologies grew revenue faster in its latest fiscal year (+163.47% vs +38.09%).

About Intelligent Bio Solutions

INBS stock →

Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform.

Health Care · Medical/Dental Instruments · 59 employees

About NeuroOne Medical Technologies

NMTC stock →

NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders.

Health Care · Medical/Dental Instruments · 18 employees

INBS vs NMTC FAQ

Which is bigger, Intelligent Bio Solutions or NeuroOne Medical Technologies?

NeuroOne Medical Technologies (NMTC) is larger, with a market capitalization of $5.94M compared with $4.61M for Intelligent Bio Solutions (INBS).

Are Intelligent Bio Solutions and NeuroOne Medical Technologies in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons